A federal jury found Takeda used an anticompetitive settlement to delay generic Amitiza, exposing the drugmaker to potentially billions in damages under federal antitrust law. The verdict is the first plaintiff win in a jury trial involving pharmaceutical pay-for-delay claims since a 2013 U.S. Supreme Court ruling.
Federal prosecutors said Brad Heppner used shell companies, falsified records, and misleading debt transactions tied to GWG Holdings and Beneficient, leaving thousands of investors facing major losses.
The Hartford says younger workers are turning to tools like ChatGPT during open enrollment as medical costs, inflation and benefit confusion increase pressure on household budgets.
New York lawmakers are trying to reopen workers’ compensation access for National Guard members who served at Ground Zero but were excluded from prior 9/11 responder coverage.
A Minnesota woman was awarded $65.5 million after a jury linked her mesothelioma to long-term use of Johnson & Johnson’s talcum powder. The company plans to appeal.
Earnings and premium growth create space for strategic reinvestment, not complacency. Insurers must manage yield, capital, and longevity risks to stay ahead.
A Tennessee judge found a hospital worker failed to meet state notice rules after alleging psychological harm from workplace events. The claim was dismissed with prejudice after the worker did not respond to the motion.
A major Pew-backed study finds global plastic pollution could nearly triple by 2040 unless sweeping system-wide reforms are implemented across industries.
As healthcare costs rise, more employers are adopting stop loss coverage to manage catastrophic medical claims. AI-driven underwriting and flexible policy structures are shaping the future of the market.
A South Florida jury found two men guilty of exploiting ACA subsidies by enrolling homeless individuals in plans they didn’t qualify for, generating millions in commissions.
PTSD and psychological injury benefits without physical harm could spark new challenges for claims adjusters, from rising costs to legislative uncertainty.
